For Sponsors & CROs

Trials that activate faster, on infrastructure that's already running.

Place your Phase II–IV trial across a multi-site network of purpose-upgraded infusion centers — with a GCP-certified investigative team and real-time visibility into site performance.

Why Sponsors Choose Us

Built for enrollment pressure

Quick Site Activation

Rapid movement from feasibility to first patient enrolled, backed by infrastructure that doesn't need to be built.

Central IRB Site

Registered with a central IRB to streamline submission and shorten startup timelines.

Advanced Recruitment

Established infusion patient populations plus modern recruitment methods to fill enrollment quickly.

GCP-Certified Team

Board-certified Principal Investigator, credentialed Sub-Investigator, and experienced Clinical Research Coordinator on staff.

CTMS With Real-Time Access

Live sponsor visibility into enrollment metrics, protocol deviations, and site performance through our cloud-based trial management system.

Fast Budget & Contracting

Experienced in Phase II–IV budget negotiation and contract execution, with fast feasibility responses and contract turnaround.

Clinical research scientist working in a laboratory
Data You Can See

Precision, oversight, and real-time visibility

A GCP-certified investigative team and a cloud-based CTMS give sponsors live insight into enrollment metrics, protocol deviations, and site performance — from feasibility through closeout.

Submit a Feasibility Inquiry →
How We Work

From feasibility to closeout

A clear, predictable path — with the infusion infrastructure already in place at every step.

1Feasibility
2IRB Submission
3Contract Execution
4Site Activation
5Patient Enrollment
6Data Lock
7Closeout
Feasibility Inquiry

Tell us about your trial

This form is for sponsors and CROs evaluating our network. For study participation, please visit For Participants.

Thank you — your feasibility inquiry has been received. Our team will follow up promptly.

Submissions are confidential. This form is separate from the general participant sign-up.